Considering the inconsistent results of SNHG5 expression in patients with different tumour types, a subgroup analysis was conducted, taking into account cancer type, sample size, cutoff value, follow-up duration, hazard ratio (HR) statistics, and analysis method. The gene discussed is SNHG5; the disease is cancer.